
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $506.5M | $563M | $1B | $1.1B | $922.7M | |
Revenue Growth (YoY) | -4.44% | 11.15% | 82.15% | 12.05% | -19.7% | |
Cost of Revenues | $289M | $344.6M | $698.3M | $818M | $598.6M | |
Gross Profit | $217.6M | $218.4M | $327.3M | $331.1M | $324.2M | |
Gross Profit Margin | 42.95% | 38.79% | 31.91% | 28.82% | 35.13% | |
R&D Expenses | $113.3M | $108.7M | $173.8M | $258.3M | $221.5M | |
Selling, General & Admin | $114M | $124.4M | $208.9M | $258.6M | $232.9M | |
Other Inc / (Exp) | $1.5M | $5.6M | -$14.3M | -$33.9M | -$293.5M | |
Operating Expenses | $227.3M | $233.1M | $382.6M | $516.9M | $454.4M | |
Operating Income | -$9.7M | -$14.7M | -$55.4M | -$185.8M | -$130.2M | |
Net Interest Expenses | -- | -- | $1.3M | $14M | $19M | |
EBT. Incl. Unusual Items | -$6.2M | -$6.3M | -$71M | -$233.6M | -$442.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$8.6M | $2.3M | -$62.1M | $28.3M | $7.3M | |
Net Income to Company | $2.4M | -$8.6M | -$8.9M | -$261.9M | -$450.1M | |
Minority Interest in Earnings | -- | -- | $6.9M | -$6.9M | -$9.8M | |
Net Income to Common Excl Extra Items | $2.4M | -$8.6M | -$2M | -$268.9M | -$459.9M | |
Basic EPS (Cont. Ops) | $0.05 | -$0.18 | -$0.03 | -$3.43 | -$5.79 | |
Diluted EPS (Cont. Ops) | $0.05 | -$0.18 | -$0.03 | -$3.43 | -$5.79 | |
Weighted Average Basic Share | $48M | $48.6M | $62.3M | $78.4M | $78.9M | |
Weighted Average Diluted Share | $48.3M | $48.6M | $62.3M | $78.4M | $78.9M | |
EBITDA | $10.4M | $9.8M | $27K | -$104.4M | -$330.1M | |
EBIT | -$6.2M | -$6.3M | -$67.5M | -$217.3M | -$420.7M | |
Revenue (Reported) | $506.5M | $563M | $1B | $1.1B | $922.7M | |
Operating Income (Reported) | -$9.7M | -$14.7M | -$55.4M | -$185.8M | -$130.2M | |
Operating Income (Adjusted) | -$6.2M | -$6.3M | -$67.5M | -$217.3M | -$420.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $127.5M | $154.5M | $323.9M | $226.2M | $247.7M | |
Revenue Growth (YoY) | 11.36% | 21.16% | 109.63% | -30.18% | 9.54% | |
Cost of Revenues | $73.9M | $100.2M | $236.1M | $155.9M | $152.6M | |
Gross Profit | $53.6M | $54.3M | $87.8M | $70.3M | $95.2M | |
Gross Profit Margin | 42.03% | 35.15% | 27.11% | 31.09% | 38.42% | |
R&D Expenses | $27.5M | $26.5M | $70.1M | $60.2M | $48.9M | |
Selling, General & Admin | $27.4M | $27.9M | $67.4M | $59M | $50.3M | |
Other Inc / (Exp) | $3M | -$3.6M | $949K | -$293.8M | -$742K | |
Operating Expenses | $54.9M | $54.4M | $137.5M | $119.2M | $99.1M | |
Operating Income | -$1.3M | -$68K | -$49.7M | -$48.9M | -$4M | |
Net Interest Expenses | -- | -- | $3M | $4.2M | $4.6M | |
EBT. Incl. Unusual Items | $1.9M | -$3.5M | -$51.8M | -$346.9M | -$9.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1M | -$2.4M | -$11.3M | -$18.6M | -$397K | |
Net Income to Company | $896K | -$1.1M | -$40.5M | -$328.2M | -$8.9M | |
Minority Interest in Earnings | -- | -- | $370K | -$2.5M | -$2.3M | |
Net Income to Common Excl Extra Items | $896K | -$1.1M | -$40.1M | -$330.8M | -$11.3M | |
Basic EPS (Cont. Ops) | $0.02 | -$0.02 | -$0.51 | -$4.20 | -$0.14 | |
Diluted EPS (Cont. Ops) | $0.02 | -$0.02 | -$0.51 | -$4.20 | -$0.14 | |
Weighted Average Basic Share | $48.3M | $49.1M | $78.4M | $78.8M | $79.5M | |
Weighted Average Diluted Share | $49M | $49.1M | $78.4M | $78.8M | $79.5M | |
EBITDA | $6.1M | $156K | -$15.1M | -$319.9M | $17M | |
EBIT | $2M | -$3.5M | -$48.5M | -$342.3M | -$4.6M | |
Revenue (Reported) | $127.5M | $154.5M | $323.9M | $226.2M | $247.7M | |
Operating Income (Reported) | -$1.3M | -$68K | -$49.7M | -$48.9M | -$4M | |
Operating Income (Adjusted) | $2M | -$3.5M | -$48.5M | -$342.3M | -$4.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $519.5M | $590M | $1.2B | $1.1B | $944.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $300M | $370.9M | $834.2M | $737.7M | $597.2M | |
Gross Profit | $219.6M | $219.1M | $360.7M | $313.6M | $347.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $110.9M | $107.7M | $217.4M | $248.4M | $210.1M | |
Selling, General & Admin | $114.8M | $124.9M | $248.4M | $250.2M | $224.1M | |
Other Inc / (Exp) | $14.3M | -$1.1M | -$9.7M | -$328.6M | -$5.2M | |
Operating Expenses | $225.7M | $232.5M | $465.8M | $498.6M | $434.2M | |
Operating Income | -$6.2M | -$13.4M | -$105.1M | -$185M | -$87.1M | |
Net Interest Expenses | -- | -- | $4.5M | $15.2M | $19.4M | |
EBT. Incl. Unusual Items | $10M | -$11.8M | -$119.2M | -$528.7M | -$111.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.2M | -$1.1M | -$71M | $21M | $25.6M | |
Net Income to Company | $13.2M | -$10.7M | -$48.2M | -$549.7M | -$130.8M | |
Minority Interest in Earnings | -- | -- | $7.2M | -$10.5M | -$10M | |
Net Income to Common Excl Extra Items | $13.2M | -$10.7M | -$41M | -$560.2M | -$147.3M | |
Basic EPS (Cont. Ops) | $0.28 | -$0.22 | -$0.54 | -$7.10 | -$1.71 | |
Diluted EPS (Cont. Ops) | $0.28 | -$0.22 | -$0.55 | -$7.10 | -$1.71 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $26.4M | $3.9M | -$15.2M | -$409.2M | $196K | |
EBIT | $10M | -$11.7M | -$112.5M | -$511.1M | -$89.5M | |
Revenue (Reported) | $519.5M | $590M | $1.2B | $1.1B | $944.3M | |
Operating Income (Reported) | -$6.2M | -$13.4M | -$105.1M | -$185M | -$87.1M | |
Operating Income (Adjusted) | $10M | -$11.7M | -$112.5M | -$511.1M | -$89.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $127.5M | $154.5M | $323.9M | $226.2M | $247.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $73.9M | $100.2M | $236.1M | $155.9M | $152.6M | |
Gross Profit | $53.6M | $54.3M | $87.8M | $70.3M | $95.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $27.5M | $26.5M | $70.1M | $60.2M | $48.9M | |
Selling, General & Admin | $27.4M | $27.9M | $67.4M | $59M | $50.3M | |
Other Inc / (Exp) | $3M | -$3.6M | $949K | -$293.8M | -$742K | |
Operating Expenses | $54.9M | $54.4M | $137.5M | $119.2M | $99.1M | |
Operating Income | -$1.3M | -$68K | -$49.7M | -$48.9M | -$4M | |
Net Interest Expenses | -- | -- | $3M | $4.2M | $4.6M | |
EBT. Incl. Unusual Items | $1.9M | -$3.5M | -$51.8M | -$346.9M | -$9.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1M | -$2.4M | -$11.3M | -$18.6M | -$397K | |
Net Income to Company | $896K | -$1.1M | -$40.5M | -$328.2M | -$8.9M | |
Minority Interest in Earnings | -- | -- | $370K | -$2.5M | -$2.3M | |
Net Income to Common Excl Extra Items | $896K | -$1.1M | -$40.1M | -$330.8M | -$11.3M | |
Basic EPS (Cont. Ops) | $0.02 | -$0.02 | -$0.51 | -$4.20 | -$0.14 | |
Diluted EPS (Cont. Ops) | $0.02 | -$0.02 | -$0.51 | -$4.20 | -$0.14 | |
Weighted Average Basic Share | $48.3M | $49.1M | $78.4M | $78.8M | $79.5M | |
Weighted Average Diluted Share | $49M | $49.1M | $78.4M | $78.8M | $79.5M | |
EBITDA | $6.1M | $156K | -$15.1M | -$319.9M | $17M | |
EBIT | $2M | -$3.5M | -$48.5M | -$342.3M | -$4.6M | |
Revenue (Reported) | $127.5M | $154.5M | $323.9M | $226.2M | $247.7M | |
Operating Income (Reported) | -$1.3M | -$68K | -$49.7M | -$48.9M | -$4M | |
Operating Income (Adjusted) | $2M | -$3.5M | -$48.5M | -$342.3M | -$4.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $60.2M | $56.6M | $108.6M | $87.2M | $76M | |
Short Term Investments | $3.1M | $350K | $340K | -- | -- | |
Accounts Receivable, Net | $98.8M | $158.7M | $279.4M | $209.7M | $178M | |
Inventory | $125.5M | $139.9M | $427.5M | $360.4M | $261.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $8.3M | $9.3M | $33.6M | $41M | $56.4M | |
Total Current Assets | $317.4M | $376.3M | $882.4M | $719M | $599.1M | |
Property Plant And Equipment | $62.4M | $55.8M | $110.7M | $118.2M | $106.5M | |
Long-Term Investments | $80.1M | $70.6M | $32.7M | $27.7M | $32.1M | |
Goodwill | $7M | $7M | $381.7M | $358.2M | $52.9M | |
Other Intangibles | $23.5M | $19.3M | $401.2M | $337.4M | $284.9M | |
Other Long-Term Assets | $25.4M | $31M | $67M | $87.7M | $78.1M | |
Total Assets | $525.7M | $569M | $1.9B | $1.7B | $1.2B | |
Accounts Payable | $49.9M | $102.5M | $237.7M | $162.9M | $171.8M | |
Accrued Expenses | $28.9M | $28.6M | $80.1M | $63.4M | $67M | |
Current Portion Of Long-Term Debt | -- | -- | $35.9M | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $94.2M | $155.4M | $428.6M | $274M | $293.5M | |
Long-Term Debt | -- | -- | $60M | $195M | $189.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $152.7M | $211.9M | $639.9M | $628.9M | $621.5M | |
Common Stock | $797K | $797K | $781K | $790K | $795K | |
Other Common Equity Adj | -- | -$11.9M | $26.1M | $47.5M | $11.3M | |
Common Equity | $372.9M | $357.1M | $974M | $605.3M | $127M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $329.7M | $443.3M | $422.9M | |
Total Equity | $372.9M | $357.1M | $1.3B | $1B | $549.9M | |
Total Liabilities and Equity | $525.7M | $569M | $1.9B | $1.7B | $1.2B | |
Cash and Short Terms | $63.3M | $57M | $109M | $87.2M | $76M | |
Total Debt | -- | -- | $120.5M | $195M | $189.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $63.8M | $54M | $136.5M | $106.8M | $106.8M | |
Short Term Investments | $4.1M | $429K | $1.1M | -- | -- | |
Accounts Receivable, Net | $103.2M | $150.1M | $262M | $187.6M | $187.6M | |
Inventory | $122.9M | $171.1M | $416.3M | $322.1M | $322.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $7.6M | $9.1M | $37M | $59.7M | $59.7M | |
Total Current Assets | $324.3M | $402.1M | $883.8M | $697M | $697M | |
Property Plant And Equipment | $60.2M | $54.4M | $112M | $127M | $109.6M | |
Long-Term Investments | $81.3M | $67.7M | $33M | $29.3M | $29.3M | |
Goodwill | $7M | $7M | $385.8M | $55.1M | $55.1M | |
Other Intangibles | $22.4M | $18.4M | $379.3M | $306.4M | $293.1M | |
Other Long-Term Assets | $26.2M | $30.5M | $63.2M | $87.7M | $87.7M | |
Total Assets | $530.8M | $589.1M | $1.9B | $1.3B | $1.3B | |
Accounts Payable | $55.5M | $127.1M | $198.6M | $159.1M | $159.1M | |
Accrued Expenses | $30.5M | $32.7M | $57.8M | $62.3M | $62.3M | |
Current Portion Of Long-Term Debt | -- | -- | $190.8M | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $102.2M | $182.8M | $522.2M | $282.7M | $282.7M | |
Long-Term Debt | -- | -- | -- | $195M | $195M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $160.4M | $236.8M | $675.8M | $620.5M | $620.5M | |
Common Stock | $797K | $797K | $787K | $791K | $791K | |
Other Common Equity Adj | -- | -- | $55.3M | $29.7M | $29.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $442.7M | $441.6M | $441.6M | |
Total Equity | $370.4M | $352.3M | $1.3B | $707.4M | $707.4M | |
Total Liabilities and Equity | $530.8M | $589.1M | $1.9B | $1.3B | $1.3B | |
Cash and Short Terms | $67.9M | $54.4M | $137.5M | $106.8M | $106.8M | |
Total Debt | -- | -- | $190.8M | $195M | $195M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.4M | -$8.6M | -$8.9M | -$261.9M | -$450.1M | |
Depreciation & Amoritzation | $16.6M | $16.1M | $67.6M | $112.9M | $90.5M | |
Stock-Based Compensation | $6.8M | $7.5M | $28.3M | $16.4M | $16M | |
Change in Accounts Receivable | -$12M | -$51.1M | -$19.3M | $84.7M | $57.5M | |
Change in Inventories | -$20.2M | -$10.6M | -$73.2M | $22.4M | $80M | |
Cash From Operations | -$16.5M | $3M | -$44.2M | -$43M | $103.6M | |
Capital Expenditures | $6.4M | $5.7M | $17.1M | $45.8M | $65.2M | |
Cash Acquisitions | -- | -- | $44M | -- | -- | |
Cash From Investing | $41.4M | $10.3M | $55.8M | -$34.9M | -$64.3M | |
Dividends Paid (Ex Special Dividend) | -$17.3M | -$17.5M | -$22.9M | -$21.2M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $10M | $141.9M | $163.7M | $26M | |
Long-Term Debt Repaid | -$24.6M | -$10M | -$65.7M | -$89.9M | -$31M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1M | -$1.9M | -$7.3M | $5.7M | -$45.8M | |
Cash From Financing | -$43M | -$13M | $52.9M | $58.9M | -$50M | |
Beginning Cash (CF) | $73.8M | $60.2M | $56.8M | $108.6M | $87.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$18.1M | $316K | $64.5M | -$19M | -$10.7M | |
Ending Cash (CF) | $60.2M | $56.8M | $108.6M | $87.2M | $76M | |
Levered Free Cash Flow | -$22.9M | -$2.7M | -$61.3M | -$88.8M | $38.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.1M | $2.1M | -$36.2M | -$40.4M | -- | |
Depreciation & Amoritzation | $4.1M | $3.6M | $34.1M | $22.8M | -- | |
Stock-Based Compensation | $1.8M | $1.9M | $4.3M | $3.8M | -- | |
Change in Accounts Receivable | -$16.9M | -$14.2M | $21.9M | -$4M | -- | |
Change in Inventories | $5.1M | -$24.3M | -$4.2M | $29.8M | -- | |
Cash From Operations | $7.5M | -$10.8M | -$16.2M | $18.6M | -- | |
Capital Expenditures | $1.5M | $1.8M | $11.7M | $14.7M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $270K | $7.5M | -$10.7M | -$14.7M | -- | |
Dividends Paid (Ex Special Dividend) | -$4.4M | -$4.4M | -$7.1M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $20M | $25.5M | -- | -- | |
Long-Term Debt Repaid | -- | -$20M | -$5.9M | -$5M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$279K | -$83K | $4.3M | -- | |
Cash From Financing | -$2.1M | -$4.7M | $12.6M | -$670K | -- | |
Beginning Cash (CF) | $63.9M | $54M | $136.5M | $106.8M | -- | |
Foreign Exchange Rate Adjustment | $353K | -$2.7M | $2.2M | $1.2M | -- | |
Additions / Reductions | $5.7M | -$8M | -$14.4M | $3.2M | -- | |
Ending Cash (CF) | $70M | $43.4M | $124.3M | $111.2M | -- | |
Levered Free Cash Flow | $6.1M | -$12.6M | -$27.9M | $3.9M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $13.2M | -$10.7M | -$48.2M | -$549.7M | -$130.8M | |
Depreciation & Amoritzation | $16.4M | $15.6M | $97.3M | $101.9M | $89.7M | |
Stock-Based Compensation | $6.9M | $7.6M | $30.2M | $16.5M | $15.2M | |
Change in Accounts Receivable | -$14.3M | -$42.6M | -$2.2M | $96.6M | $40.1M | |
Change in Inventories | -$14.6M | -$44.3M | -$46.3M | $57.5M | $58M | |
Cash From Operations | -$5.8M | -$2.8M | -$69M | $14.8M | $108.8M | |
Capital Expenditures | $5.7M | $6.4M | $24.1M | $52M | $69.2M | |
Cash Acquisitions | -- | -- | $44M | -- | -- | |
Cash From Investing | $11.8M | $9.6M | $51.7M | -$41.9M | -$68.7M | |
Dividends Paid (Ex Special Dividend) | -$17.4M | -$17.6M | -$25.5M | -$14.2M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $18M | $272.1M | $25.5M | -- | |
Long-Term Debt Repaid | -- | -$18M | -$125.9M | -$21.7M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$1.8M | -$14.6M | $8.8M | -$41.9M | |
Cash From Financing | -$17.3M | -$13.7M | $112.5M | -$923K | -$45.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$11.3M | -$6.9M | $95.2M | -$28M | -$5.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$11.6M | -$9.2M | -$93.1M | -$37.2M | $39.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6M | $1M | -$76.7M | -$368.7M | -$8.9M | |
Depreciation & Amoritzation | $8.2M | $7.2M | $67.5M | $45.2M | $21.6M | |
Stock-Based Compensation | $3.6M | $3.8M | $8.1M | $7.8M | $3.2M | |
Change in Accounts Receivable | -$22.9M | -$11.7M | $41.5M | $27.5M | $14.2M | |
Change in Inventories | $9.1M | -$54M | -$6.9M | $62.2M | $10.3M | |
Cash From Operations | $18.2M | -$5.9M | -$36.2M | $56.5M | $43.2M | |
Capital Expenditures | $2.2M | $3.3M | $20.1M | $29.4M | $18.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.7M | $4.8M | -$17.5M | -$28.5M | -$18.3M | |
Dividends Paid (Ex Special Dividend) | -$8.7M | -$8.9M | -$14.2M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $28M | $163.7M | -- | -- | |
Long-Term Debt Repaid | -- | -$28M | -$74M | -$5M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$113K | -$333K | -$7.5M | -$51K | -$432K | |
Cash From Financing | -$5.3M | -$8.6M | $68.2M | -$4.8M | $324K | |
Beginning Cash (CF) | $124.1M | $110.8M | $245.1M | $193.9M | $76M | |
Foreign Exchange Rate Adjustment | -$1.4M | -$3.7M | $1.1M | $888K | $133K | |
Additions / Reductions | $11.2M | -$9.7M | $14.6M | $23.1M | $25.2M | |
Ending Cash (CF) | $133.9M | $97.4M | $260.8M | $217.9M | $101.3M | |
Levered Free Cash Flow | $16M | -$9.2M | -$56.3M | $27.1M | $24.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.